COMMUNIQUÉS West-GlobeNewswire

China FDA Approval for Oscar 2 Blood Pressure Monitor with CardieX’s "SphygmoCor® Inside" Technology
24/04/2019
SYDNEY, Australia, April 23, 2019 (GLOBE NEWSWIRE) -- CardieX Limited (Australian Stock Exchange listed: CDX) announces approval by the Chinese Food and Drug Administration (CFDA) of the Oscar 2 with “ SphygmoCor® [...]
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
24/04/2019
LA JOLLA, Calif., April 23, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
Psychemedics Announces First Quarter Results and Declares 91st Consecutive Quarterly Dividend
23/04/2019
ACTON, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2019. The Company also announced a quarterly dividend [...]
Harvard Bioscience Schedules First Quarter 2019 Conference Call for May 2 at 4:30 PM ET
23/04/2019
HOLLISTON, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results [...]
Emerald Health Therapeutics annonce que la serre Delta 3 de Pure Sunfarms est entièrement semée ; la société présentera ses résultats financiers de fin d'année le 1er mai
23/04/2019
Pure Sunfarms en voie d'atteindre un rythme de production annualisé de 75 000 kilogrammes d'ici la mi-2019 La société organisera une conférence téléphonique pour présenter ses résultats financiers du quatrième trimestre [...]
Retrophin to Report First Quarter 2019 Financial Results
23/04/2019
SAN DIEGO, April 23, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced it will report first quarter 2019 financial results on Tuesday, May 7, 2019 after the close of the U.S. financial markets. The [...]
ReWalk Robotics to Present at the ThinkEquity Conference on May 2nd
23/04/2019
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 23, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Andy Dolan [...]
Stryker reports first quarter 2019 operating results
23/04/2019
Kalamazoo, Michigan, April 23, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2019: First Quarter Highlights Reported net sales increased 8.5% to $3.5 billion Organic net [...]
Myriad to Announce Fiscal Third-Quarter 2019 Financial Results on May 7, 2019
23/04/2019
SALT LAKE CITY, April 23, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that it will hold its fiscal third-quarter 2019 sales and earnings conference [...]
Diversicare to Announce First Quarter 2019 Financial Results on Thursday, May 2, 2019
23/04/2019
BRENTWOOD, Tenn., April 23, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its first quarter ended March 31, 2019, on [...]
NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Million
23/04/2019
ST. LOUIS PARK, Minn., April 23, 2019 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve [...]
Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
23/04/2019
Mechelen, Belgium and Planegg/Munich, Germany; 23 April 2019; 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG), MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR) and Novartis Pharma AG (SIX: NOVN [...]
Merit Medical Reports Earnings for Quarter Ended March 31, 2019
23/04/2019
Q1 2019 worldwide revenue of $238.3 million, up 17.4% as reported over Q1 2018 Q1 2019 core revenue on a comparable, constant currency basis* up 10.0% over Q1 2018 Q1 2019 GAAP EPS was $0.11, compared to $0.10 in Q1 [...]
Akari Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
23/04/2019
Treatment with Nomacopan (Coversin) in three patients with mild-to-moderate bullous pemphigoid (BP) resulted in no drug-related adverse events and rapid reduction in BP Disease Area Index (BPDAI) score and blistering in [...]
VitalHub Continues to Report Positive Adjusted EBITDA Results and Increased Revenues
23/04/2019
TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]
Tonix Pharmaceuticals Announces Update on the Collaborative Research and Development Agreement (CRADA) with the U.S. Army Medical Materiel Development Activity (USAMMDA)
23/04/2019
The Termination Does Not Affect Tonix’s Finances or the Ongoing RECOVERY Trial of Tonmya® for the Treatment of PTSD NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix [...]
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Conference Call on May 6, 2019
23/04/2019
LONDON, April 23, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
Alberta healthcare initiatives recognized for making an impact on patients’ experiences
23/04/2019
CALGARY, Alberta, April 23, 2019 (GLOBE NEWSWIRE) -- The Health Quality Council of Alberta (HQCA) has recognized four initiatives in the province that are making a positive impact on Albertans’ experiences receiving [...]
New Peer Reviewed Data Supports Use of Conformis Customized Knee Implants to Match Anatomic Variability in Patients
23/04/2019
BILLERICA, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint [...]

Pages